Anhui Anke Biotechnology (Group) Co., Ltd. (SZSE:300009) agreed to acquire 11.31% stake in Anhui Xinhuakun Biological Engineering Co., Ltd. from a group of shareholders for CNY 10.3 million on December 12, 2023. As of June 30, 2023, Anhui Xinhuakun Biological Engineering Co., Ltd. generated, total assets of CNY 92.6281 million and net assets of 89.7 million. The transaction is approved by board of directors of Anhui Anke Biotechnology (Group) Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.97 CNY | +0.40% | +2.05% | -2.45% |
Apr. 25 | Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 28 | Anhui Anke Biotechnology Co., Ltd. Proposes Final Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.45% | 2.29B | |
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-14.82% | 15.36B | |
-8.82% | 11.95B | |
-16.29% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- 300009 Stock
- News Anhui Anke Biotechnology (Group) Co., Ltd.
- Anhui Anke Biotechnology Co., Ltd. agreed to acquire 11.31% stake in Anhui Xinhuakun Biological Engineering Co., Ltd. from a group of shareholders for CNY 10.3 million.